Copper and Alzheimer's disease

Current Opinion in Chemical Biology

Volumn 11, Issue 2, 2007, Pages 128-133

  Donnelly, Paul S ^a   Xiao, Zhiguang ^a   Wedd, Anthony G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CLIOQUINOL; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; PRION PROTEIN;

ALZHEIMER DISEASE; BRAIN METABOLISM; COPPER METABOLISM; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DISEASE COURSE; DRUG MECHANISM; HOMEOSTASIS; HUMAN; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; BASE SEQUENCE; COPPER; HOMEOSTASIS; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 34047276442     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2007.01.678     Document Type: Review

References (46)

1. Dobson C.M. Protein folding and misfolding. Nature 426 (2003) 884-890
2. Selkoe D.J. Folding proteins in fatal ways. Nature 426 (2003) 900-904
3. Burdette S.C., and Lippard S.J. Meeting of the minds: metalloneurochemistry. Proc Natl Acad Sci USA 100 (2003) 3605-3610
4. Frederickson C.J., Suh S.W., Silva D., Frederickson C.J., and Thompson R.B. Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr 130 (2000) 1471S-1483S
5. White A.R., Barnham K.J., and Bush A.I. Metal homeostasis in Alzheimer's disease. Expert Rev Neurother 6 (2006) 711-722. Recent review that focuses on the proposed roles of iron, copper and zinc in Alzheimer's disease.
6. Gaggelli E., Kozlowski H., Valensin D., and Valensin G. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Chem Rev 106 (2006) 1995-2044. Highly recommended review covering detailed molecular aspects of the role of copper in neurodegenerative diseases.
7. In: Sigel A., Sigel H., and Sigel R.K.O. (Eds). Neurodegenerative Diseases and Metal Ions: Metal Ions in Life Sciences Vol 1 (2006), Wiley Volume which contains 13 relevant articles
8. Barnham K.J., Cappai R., Beyreuther K., Masters C.L., and Hill A.F. Delineating common molecular mechanisms in Alzheimer's and prion diseases. Trends Biochem Sci 31 (2006) 465-472
9. Gaeta A., and Hider R.C. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol 146 (2005) 1041-1059
10. Valentine J.S., Doucette P.A., and Potter S.Z. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74 (2005) 563-593. Up-to-date account of the molecular understanding of this condition.
11. Brown D.R., and Kozlowski H. Biological inorganic and bioinorganic chemistry of neurodegeneration based on prion and Alzheimer diseases. Dalton Trans (2004) 1907-1917
12. Barnham K.J., Masters C.L., and Bush A.I. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3 (2004) 205-214. The focus of this article is on the implications of oxidative stress in the brain, the potential involvement of metal ions and possible therapeutic options.
13. Institute of Medicine, Food Nutrition Board. Dietary Reference Intakes for Vitamin A: Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc (2000), National Academy Press, Washington DC Chapter 7
14. Finney L.A., and O'Halloran T.V. Transition metal speciation in the cell: insights from the chemistry of metal ion receptors. Science 300 (2003) 931-936
15. Pena M.M.O., Lee J., and Thiele D.J. A delicate balance: homeostatic control of copper uptake and distribution. J Nutr 129 (1999) 1251-1260
16. Rae T.D., Schmidt P.J., Pufahl R.A., Culotta V.C., and O'Halloran T.V. Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science 284 (1999) 805-808
17. Zhou B., and Gitschier J. hCTR1: a human gene for copper uptake identified by complementation in yeast. Proc Natl Acad Sci USA 94 (1997) 7481-7486
18. Kuo Y.M., Zhou B., Cosco D., and Gitschier J. The copper transporter CTR1 provides an essential function in mammalian embryonic development. Proc Natl Acad Sci USA 98 (2001) 6836-6841
19. Nose Y., Rees E.M., and Thiele D.J. Structure of the Ctr1 copper trans'PORE'ter reveals novel architecture. Trends Biochem Sci 31 (2006) 604-607. This review summarizes the molecular aspects of a key copper transporter (cf, Figure 1).
20. Lee J., Prohaska J.R., Dagenais S.L., Glover T.W., and Thiele D.J. Isolation of a murine copper transporter gene, tissue specific expression and functional complementation of a yeast copper transport mutan. Gene 254 (2000) 87-96
21. Eisses J.F., and Kaplan J.H. The mechanism of copper uptake mediated by human CTR1: a mutational analysis. J Biol Chem 280 (2005) 37159-37168
22. Ali F.E.A., Barnham K.J., Barrow C.J., and Separovic F. Metal-catalyzed oxidative damage and oligomerization of the amyloid-β peptide of Alzheimer's disease. Aust J Chem 57 (2004) 511-518
23. Cohen E., Bieschke J., Perciavalle R.M., Kelly J.W., and Dillin A. Opposing activities protect against age-onset proteotoxicity. Science 313 (2006) 1604-1610
24. White A.R., Reyes R., Mercer J.F.B., Camakaris J., Zheng H., Bush A.I., Multhaup G., Beyreuther K., Masters C.L., and Cappai R. Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res 842 (1999) 439-444
25. Maynard C.J., Cappai R., Volitakis I., Cherny R.A., White A.R., Beyreuther K., Masters C.L., Bush A.I., and Li Q.-X. Overexpression of Alzheimer's disease amyloid-β opposes the age-dependent elevations of brain copper and iron. J Biol Chem 277 (2002) 44670-44676
26. Maynard C.J., Cappai R., Volitakis I., Cherny R.A., Masters C.L., Li Q.-X., and Bush A.I. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: Implications for Alzheimer β-amyloid pathology. J Inorg Biochem 100 (2006) 952-962
27. Barnham K.J., McKinstry W.J., Multhaup G., Galatis D., Morton C.J., Curtain C.C., Williamson N.A., White A.R., Hinds M.G., Norton R.S., et al. Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. J Biol Chem 278 (2003) 17401-17407
28. Kong G.K., Galatis D., Barnham K.J., Polekhina G., Adams J.J., Masters C.L., Cappai R., Parker M.W., and McKinstry W.J. Crystallization and preliminary crystallographic studies of the copper-binding domain of the amyloid precursor protein of Alzheimer's disease. Acta Crystallograph Sect F Struct Biol Cryst Commun 61 (2005) 93-95
29. Curtain C.C., Ali F., Volitakis I., Cherny R.A., Norton R.S., Beyreuther K., Barrow C.J., Masters C.L., Bush A.I., and Barnham K.J. Alzheimer's disease amyloid-β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J Biol Chem 276 (2001) 20466-20473
30. Cherny R.A., Legg J.T., McLean C.A., Fairlie D.P., Huang X., Atwood C.S., Beyreuther K., Tanzi R.E., Masters C.L., and Bush A.I. Aqueous dissolution of Alzheimer's disease Aβ amyloid deposits by biometal depletion. J Biol Chem 274 (1999) 23223-23228
31. II sites in Aβ peptide species in monomers and aggregates.
32. 2+ in a mononuclear metal ion binding site. J Am Chem Soc 126 (2004) 13534-13538
33. Miura T., Suzuki K., Kohata N., and Takeuchi H. Metal binding modes of Alzheimer's amyloid β-peptide in insoluble aggregates and soluble complexes. Biochemistry 39 (2000) 7024-7031
34. II binding to native Aβ(1-40) peptide. Earlier studies used Aβ(1-16) or Aβ(1-28) peptides.
35. Huang X., Cuajungco M.P., Atwood C.S., Hartshorn M.A., Tyndall J.D.A., Hanson G.R., Stokes K.C., Leopold M., Multhaup G., Goldstein L.E., et al. Cu(II) potentiation of Alzheimer Aβ neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem 274 (1999) 37111-37116
36. Bayer T.A., and Multhaup G. Involvement of amyloid β precursor protein (AβPP) modulated copper homeostasis in Alzheimer's disease. J Alzheimers Dis 8 (2005) 201-206. Review of data suggesting that a deficiency of copper in the central nervous system is related to AD progression.
37. Phinney A.L., Drisaldi B., Schmidt S.D., Lugowski S., Coronado V., Liang Y., Horne P., Yang J., Sekoulidis J., Coomaraswamy J., et al. In vivo reduction of amyloid-β by a mutant copper transporter. Proc Natl Acad Sci USA 100 (2003) 14193-14198
38. Bayer T.A., Schaefer S., Simons A., Kemmling A., Kamer T., Tepest R., Eckert A., Schuessel K., Eikenberg O., Sturchler-pierrat C., et al. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice. Proc Natl Acad Sci USA 100 (2003) 14187-14192
39. ••] support the theory that a mild copper deficiency might contribute to AD progression.
40. ••].
41. Cherny R.A., Atwood C.S., Xilinas M.E., Gray D.N., Jones W.D., McLean C.A., Barnham K.J., Volitakis I., Fraser F.W., Kim Y.-S., et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30 (2001) 665-676
42. Ritchie C.W., Bush A.I., Mackinnon A., Macfarlane S., Mastwyk M., MacGregor L., Kiers L., Cherny R., Li Q.-X., Tammer A., et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Aβ amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60 (2003) 1685-1691
43. White A.R., Du T., Laughton K.M., Volitakis I., Sharples R.A., Xilinas M.E., Hoke D.E., Holsinger R.M.D., Evin G., Cherny R.A., et al. Degradation of the Alzheimer disease amyloid β-peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem 281 (2006) 17670-17680. Metal complexes activated cell-signalling pathways that upregulated matrix metalloprotease enzymes capable of degrading the Aβ peptide.
44. Dong J., Schokes J.E., Scott R.A., and Lynn D.G. Modulating amyloid self-assembly and fibril morphology with Zn(II). J Am Chem Soc 128 (2006) 3540-3542
45. Mercer J.F.B., and Llanos R.M. Molecular and cellular aspects of copper transport in developing mammals. J Nutr 133 (2003) 1481S-1484S
46. Shim H., and Harris Z.L. Genetic defects in copper metabolism. J Nutr 133 (2003) 1527S-1531S